Carlie K. Thompson, MD
Institutional Affiliation
Education
Fellowship
Internship
Degree
Residencies
Board Certification
Contact Information
Phone
Scientific Interests
Dr. Carlie Thompson's research interests include breast cancer screening, the evaluation and treatment of ductal carcinoma in situ and the neoadjuvant treatment of breast cancer.
Highlighted Publications
Lindstrom LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjold B, Stal O, Benz CC, Fornander T, Borowsky AD, Esserman LJ; STO Trialists Group. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst. 2018 Jul 1;110(7):726-733. doi: 10.1093/jnci/djx270.
Esserman LJ, Yau C, Thompson CK, van 't Veer LJ, Borowsky AD, Hoadley KA, Tobin NP, Nordenskjold B, Fornander T, Stal O, Benz CC, Lindstrom LS. Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades. JAMA Oncol. 2017 Nov 1;3(11):1503-1510. doi: 10.1001/jamaoncol.2017.1261.
Esserman LJ; WISDOM Study and Athena Investigators. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017 Sep 13;3:34. doi: 10.1038/s41523-017-0035-5. eCollection 2017. Review.
Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA; Athena Breast Health Network Investigators. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 Jan 27;109(5). doi: 10.1093/jnci/djw290. Print 2017 Jan. Review.
Thompson CK, Eklund M, Esserman LJ. Putting the "Great Mammography Debate" to rest. Am J Hematol Oncol. 2015 Sep;11(9):21-2.
